Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2014)
✉ Email this page to a colleague
ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2014)
| Docket | ⤷ Subscribe | Date Filed | 2014-06-03 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-08-01 |
| Cause | 35:271 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | Defendant | Referred To | Karen M. Williams |
| Patents | 6,774,122; 7,456,160; 8,329,680; 8,466,139 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Details for ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-06-03 | 1 | THE PATENTS-IN-SUIT 17. United States Patent No. 6,774,122 (the “’122 patent”), entitled…to the expiration of AstraZeneca’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. … COUNT I: INFRINGEMENT OF U.S. PATENT NO. 6,774,122 31. Plaintiffs hereby reallege…INFRINGEMENT OF U.S. PATENT NO. 6,774,122 42. Plaintiffs hereby reallege…12. This is a civil action for patent infringement under the patent laws of the United States, Title | External link to document | |
| 2016-03-30 | 194 | ORDER, Covenant Not to Sue Regarding U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. Signed…2014 1 August 2016 1:14-cv-03547 830 Patent Defendant District Court, D. New Jersey | External link to document | |
| 2016-06-20 | 261 | COUNT IX (U.S. Patent No. 6,774,122 Is Not Unenforceable) … Patent, the ’160 Patent, the ’680 Patent, and the ’139 Patent as the …Sagent’s counterclaims as to the ’160 patent because that patent is no longer alleged to be infringed …Sagent’s counterclaims as to the ’160 patent because that patent is no longer alleged to be infringed … ’122 patent, and that AstraZeneca UK Limited is the beneficial owner of the ’122 patent. AstraZeneca | External link to document | |
| 2016-07-12 | 316 | from infringing United States Patent Numbers 6,774,122, 7,456,160, 8,329,680 and 8,466,139, on…2014 1 August 2016 1:14-cv-03547 830 Patent Defendant District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
